Researchers use ddPCR to monitor quality at each stage of therapy development.

The achievement bolsters hopes that nonhuman animals could be used to remedy the shortage of transplantable organs.

The Albert Einstein College of Medicine neuroscientist has revealed surprising functions of the brain region, such as its role in the brain’s rewards circuits and in addiction.

The new policy will increase scrutiny and pressure on stem cell clinics, according to industry experts.

Two coauthors of a new study discuss their findings about nearly 170 facilities in the southwestern US selling unproven therapies—and what should be done about them.

More than one-fifth of individuals treated with the genetically modified virus survived at least three years.

Combining genomic, clinical, and patient-reported data, the Metastatic Breast Cancer Project provides a unique resource for the cancer community.

The legislation removes restrictions for seriously ill patients to access experimental treatments that have not received FDA approval.

With few resources and hesitant investors, basic scientists must rely on clinicians, patient advocates, and their own keen eye for biological connections.

The change should allow patients with fatal illnesses easier access to experimental drugs, but gaining permission from drug companies remains the biggest challenge.

Researchers pinpoint the source of the current Ebola outbreak in West Africa to 2-year-old boy who died in southern Guinea.

The ALS Association has raised more than $100 million in donations through a charity campaign that went viral. How should that money be spent?

Tailoring ethical oversight to participant-led research

Although fully organized patient-run trials are still few and far between, patients are taking a more active role in clinical research.

Patients are sidestepping clinical research and using themselves as guinea pigs to test new treatments for fatal diseases. Will they hurt themselves, or science?

Renowned cancer researcher Lewis Cantley is leaving Harvard to lead a new cancer center at Weill Cornell Medical College and NewYork-Presbyterian Hospital.

Giving researchers access to the health records of 52 million people in England could prove invaluable to biomedical scientists.

Members of the Personal Genome Project have created software aimed at helping researchers tease apart genetic differences between individuals.